- $10.31bn
- $4.40bn
- $3.24bn
- 88
- 38
- 32
- 52
REG - Stock Exch Notice - Admission to Trading - 25/10/2024
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 07/10/2024
AnnouncementREG - Leverage Shares PLC - Leverage Shares - A&R Margin Account Agreement
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 02/10/2024
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 26/09/2024
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 09/09/2024
AnnouncementREG - Official List - Official List Notice
AnnouncementRCS - Moderna Inc - Moderna’s COVID-19 Vaccine SARS-COV-2 Variant JN.1
AnnouncementREG - Stock Exch Notice - Admission to Trading - 02/09/2024
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 30/08/2024
AnnouncementREG - Stock Exch Notice - Admission to Trading - 27/08/2024
AnnouncementREG - Official List - Official List Notice
AnnouncementRCS - Moderna Inc - Moderna Receives Approval for RSV Vaccine mRESVIA
Announcement